Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units

L. A. Szczech, P. S. Klassen, B. Chua, S. S. Hedayati, M. Flanigan, W. M. McClellan, D. N. Reddan, R. A. Rettig, D. L. Frankenfield, W. F. Owen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Prior studies observing greater mortality in for-profit dialysis units have not captured information about benchmarks of care. This study was undertaken to examine the association between profit status and mortality while achieving benchmarks. Utilizing data from the US Renal Data System and the Centers for Medicare & Medicaid Services' end-stage renal disease (ESRD) Clinical Performance Measures project, hemodialysis units were categorized as for-profit or not-for-profit. Associations with mortality at 1 year were estimated using Cox regression. Two thousand six hundred and eighty-five dialysis units (31 515 patients) were designated as for-profit and 1018 (15 085 patients) as not-for-profit. Patients in for-profit facilities were more likely to be older, black, female, diabetic, and have higher urea reduction ratio (URR), hematocrit, serum albumin, and transferrin saturation. Patients (19.4 and 18.6%) in for-profit and not-for-profit units died, respectively. In unadjusted analyses, profit status was not associated with mortality (hazard ratio (HR) = 1.04, P = 0.09). When added to models with profit status, the following resulted in a significant association between profit status (for-profit vs not-for-profit) and increasing mortality risk: URR, hematocrit, albumin, and ESRD Network. In adjusted models, patients in for-profit facilities had a greater death risk (HR 1.09, P = 0.004). More patients in for-profit units met clinical benchmarks. Survival among patients in for-profit units was similar to not-for-profit units. This suggests that in the contemporary era, interventions in for-profit dialysis units have not impaired their ability to deliver performance benchmarks and do not affect survival.

Original languageEnglish (US)
Pages (from-to)2094-2100
Number of pages7
JournalKidney International
Volume69
Issue number11
DOIs
StatePublished - Jun 2006

Fingerprint

Benchmarking
Dialysis
Mortality
Hematocrit
Chronic Kidney Failure
Urea
Aptitude
Survival
Medicaid
Risk Reduction Behavior
Transferrin
Medicare
Information Systems
Serum Albumin
Renal Dialysis
Albumins
Odds Ratio
Kidney

Keywords

  • Economics
  • End-stage renal disease
  • Medicare
  • Mortality
  • Outcomes

ASJC Scopus subject areas

  • Nephrology

Cite this

Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units. / Szczech, L. A.; Klassen, P. S.; Chua, B.; Hedayati, S. S.; Flanigan, M.; McClellan, W. M.; Reddan, D. N.; Rettig, R. A.; Frankenfield, D. L.; Owen, W. F.

In: Kidney International, Vol. 69, No. 11, 06.2006, p. 2094-2100.

Research output: Contribution to journalArticle

Szczech, LA, Klassen, PS, Chua, B, Hedayati, SS, Flanigan, M, McClellan, WM, Reddan, DN, Rettig, RA, Frankenfield, DL & Owen, WF 2006, 'Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units', Kidney International, vol. 69, no. 11, pp. 2094-2100. https://doi.org/10.1038/sj.ki.5000267
Szczech, L. A. ; Klassen, P. S. ; Chua, B. ; Hedayati, S. S. ; Flanigan, M. ; McClellan, W. M. ; Reddan, D. N. ; Rettig, R. A. ; Frankenfield, D. L. ; Owen, W. F. / Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units. In: Kidney International. 2006 ; Vol. 69, No. 11. pp. 2094-2100.
@article{463ae7f6dfcf48abb827c55c752ad745,
title = "Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units",
abstract = "Prior studies observing greater mortality in for-profit dialysis units have not captured information about benchmarks of care. This study was undertaken to examine the association between profit status and mortality while achieving benchmarks. Utilizing data from the US Renal Data System and the Centers for Medicare & Medicaid Services' end-stage renal disease (ESRD) Clinical Performance Measures project, hemodialysis units were categorized as for-profit or not-for-profit. Associations with mortality at 1 year were estimated using Cox regression. Two thousand six hundred and eighty-five dialysis units (31 515 patients) were designated as for-profit and 1018 (15 085 patients) as not-for-profit. Patients in for-profit facilities were more likely to be older, black, female, diabetic, and have higher urea reduction ratio (URR), hematocrit, serum albumin, and transferrin saturation. Patients (19.4 and 18.6{\%}) in for-profit and not-for-profit units died, respectively. In unadjusted analyses, profit status was not associated with mortality (hazard ratio (HR) = 1.04, P = 0.09). When added to models with profit status, the following resulted in a significant association between profit status (for-profit vs not-for-profit) and increasing mortality risk: URR, hematocrit, albumin, and ESRD Network. In adjusted models, patients in for-profit facilities had a greater death risk (HR 1.09, P = 0.004). More patients in for-profit units met clinical benchmarks. Survival among patients in for-profit units was similar to not-for-profit units. This suggests that in the contemporary era, interventions in for-profit dialysis units have not impaired their ability to deliver performance benchmarks and do not affect survival.",
keywords = "Economics, End-stage renal disease, Medicare, Mortality, Outcomes",
author = "Szczech, {L. A.} and Klassen, {P. S.} and B. Chua and Hedayati, {S. S.} and M. Flanigan and McClellan, {W. M.} and Reddan, {D. N.} and Rettig, {R. A.} and Frankenfield, {D. L.} and Owen, {W. F.}",
year = "2006",
month = "6",
doi = "10.1038/sj.ki.5000267",
language = "English (US)",
volume = "69",
pages = "2094--2100",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Associations between CMS's Clinical Performance Measures project benchmarks, profit structure, and mortality in dialysis units

AU - Szczech, L. A.

AU - Klassen, P. S.

AU - Chua, B.

AU - Hedayati, S. S.

AU - Flanigan, M.

AU - McClellan, W. M.

AU - Reddan, D. N.

AU - Rettig, R. A.

AU - Frankenfield, D. L.

AU - Owen, W. F.

PY - 2006/6

Y1 - 2006/6

N2 - Prior studies observing greater mortality in for-profit dialysis units have not captured information about benchmarks of care. This study was undertaken to examine the association between profit status and mortality while achieving benchmarks. Utilizing data from the US Renal Data System and the Centers for Medicare & Medicaid Services' end-stage renal disease (ESRD) Clinical Performance Measures project, hemodialysis units were categorized as for-profit or not-for-profit. Associations with mortality at 1 year were estimated using Cox regression. Two thousand six hundred and eighty-five dialysis units (31 515 patients) were designated as for-profit and 1018 (15 085 patients) as not-for-profit. Patients in for-profit facilities were more likely to be older, black, female, diabetic, and have higher urea reduction ratio (URR), hematocrit, serum albumin, and transferrin saturation. Patients (19.4 and 18.6%) in for-profit and not-for-profit units died, respectively. In unadjusted analyses, profit status was not associated with mortality (hazard ratio (HR) = 1.04, P = 0.09). When added to models with profit status, the following resulted in a significant association between profit status (for-profit vs not-for-profit) and increasing mortality risk: URR, hematocrit, albumin, and ESRD Network. In adjusted models, patients in for-profit facilities had a greater death risk (HR 1.09, P = 0.004). More patients in for-profit units met clinical benchmarks. Survival among patients in for-profit units was similar to not-for-profit units. This suggests that in the contemporary era, interventions in for-profit dialysis units have not impaired their ability to deliver performance benchmarks and do not affect survival.

AB - Prior studies observing greater mortality in for-profit dialysis units have not captured information about benchmarks of care. This study was undertaken to examine the association between profit status and mortality while achieving benchmarks. Utilizing data from the US Renal Data System and the Centers for Medicare & Medicaid Services' end-stage renal disease (ESRD) Clinical Performance Measures project, hemodialysis units were categorized as for-profit or not-for-profit. Associations with mortality at 1 year were estimated using Cox regression. Two thousand six hundred and eighty-five dialysis units (31 515 patients) were designated as for-profit and 1018 (15 085 patients) as not-for-profit. Patients in for-profit facilities were more likely to be older, black, female, diabetic, and have higher urea reduction ratio (URR), hematocrit, serum albumin, and transferrin saturation. Patients (19.4 and 18.6%) in for-profit and not-for-profit units died, respectively. In unadjusted analyses, profit status was not associated with mortality (hazard ratio (HR) = 1.04, P = 0.09). When added to models with profit status, the following resulted in a significant association between profit status (for-profit vs not-for-profit) and increasing mortality risk: URR, hematocrit, albumin, and ESRD Network. In adjusted models, patients in for-profit facilities had a greater death risk (HR 1.09, P = 0.004). More patients in for-profit units met clinical benchmarks. Survival among patients in for-profit units was similar to not-for-profit units. This suggests that in the contemporary era, interventions in for-profit dialysis units have not impaired their ability to deliver performance benchmarks and do not affect survival.

KW - Economics

KW - End-stage renal disease

KW - Medicare

KW - Mortality

KW - Outcomes

UR - http://www.scopus.com/inward/record.url?scp=33745278005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745278005&partnerID=8YFLogxK

U2 - 10.1038/sj.ki.5000267

DO - 10.1038/sj.ki.5000267

M3 - Article

C2 - 16732194

AN - SCOPUS:33745278005

VL - 69

SP - 2094

EP - 2100

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 11

ER -